These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 17670917

  • 1. Cost-effectiveness of the interventions in the primary prevention of diabetes among Asian Indians: within-trial results of the Indian Diabetes Prevention Programme (IDPP).
    Ramachandran A, Snehalatha C, Yamuna A, Mary S, Ping Z.
    Diabetes Care; 2007 Oct; 30(10):2548-52. PubMed ID: 17670917
    [Abstract] [Full Text] [Related]

  • 2. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).
    Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, Indian Diabetes Prevention Programme (IDPP).
    Diabetologia; 2006 Feb; 49(2):289-97. PubMed ID: 16391903
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist: analysis of the Indian Diabetes Prevention Programmes (IDPP-1 and IDPP-2).
    Ramachandran A, Arun N, Shetty AS, Snehalatha C.
    Diabetes Care; 2010 Oct; 33(10):2164-8. PubMed ID: 20519663
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Metabolic syndrome does not increase the risk of conversion of impaired glucose tolerance to diabetes in Asian Indians--Result of Indian diabetes prevention programme.
    Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V.
    Diabetes Res Clin Pract; 2007 May; 76(2):215-8. PubMed ID: 16982107
    [Abstract] [Full Text] [Related]

  • 8. The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial.
    Weber MB, Ranjani H, Staimez LR, Anjana RM, Ali MK, Narayan KM, Mohan V.
    Diabetes Care; 2016 Oct; 39(10):1760-7. PubMed ID: 27504014
    [Abstract] [Full Text] [Related]

  • 9. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE, Diabetes Prevention Program Research Group.
    Ann Intern Med; 2005 Mar 01; 142(5):323-32. PubMed ID: 15738451
    [Abstract] [Full Text] [Related]

  • 10. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).
    Snehalatha C, Mary S, Selvam S, Sathish Kumar CK, Shetty SB, Nanditha A, Ramachandran A.
    Diabetes Care; 2009 Oct 01; 32(10):1796-801. PubMed ID: 19587369
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004 Oct 01; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 13. The changing cost to prevent diabetes: A retrospective analysis of the Diabetes Prevention Program.
    Carris NW, Cheng F, Kelly WN.
    J Am Pharm Assoc (2003); 2017 Oct 01; 57(6):717-722. PubMed ID: 28807660
    [Abstract] [Full Text] [Related]

  • 14. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2).
    Ramachandran A, Snehalatha C, Mary S, Selvam S, Kumar CK, Seeli AC, Shetty AS.
    Diabetologia; 2009 Jun 01; 52(6):1019-26. PubMed ID: 19277602
    [Abstract] [Full Text] [Related]

  • 15. Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors: results of the Indian Diabetes Prevention Programme.
    Snehalatha C, Mary S, Joshi VV, Ramachandran A.
    Diab Vasc Dis Res; 2008 Mar 01; 5(1):25-9. PubMed ID: 18398809
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.